However, linking its concentrations with early changes in anti-PR3 activity that is contained within the serum, and with CRP that represents nonspecific inflammatory status and widespread tissue injury, did predict the occurrence of acute GVHD, perhaps signifying early failure of immunoregulation in the face of underlying widespread tissue damage. The gene discussed is PRTN3; the disease is acute graft versus host disease.